Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer.
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
metastatic pancreatic cancer,somatic homologous recombination repair,dostarlimab,niraparib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要